Price movement over the last 24 hours
ARK Genomic Revolution ETF vs Clear Secure Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Clear Secure Inc trades at $55.25 (market cap $5.56B). The key difference: Clear Secure Inc pays a 1.09% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | YOU | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $62.36 |
52-Week Low | $23.09 | $28.38 |
Market Cap | — | $5.56B |
Enterprise Value | — | $4.88B |
Dividend Yield | — | 1.09% |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Clear Secure (YOU) trades at $55.22, down 1.6% on the day, with a bullish technical signal from moving averages and strong fundamental growth. Recent earnings beat expectations in Q1 2026, and the company expanded services with AWS integration and new airport launches. Revenue reached $900.78M in 2025, with net income of $109.17M and robust cash flow from operations of $372.45M.
Outlook remains positive due to earnings momentum and strategic expansions, but risks include high valuation multiples and competitive pressures. Analyst consensus is mixed with a $56.67 price target, suggesting moderate upside potential from current levels amid balanced sentiment.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.
Read more on YOU →